Concepedia

Scott T. Rottinghaus

ST

24

Publications

2.8K

Citations

18

H-Index

1994

Active since

Affiliations

Alexion Pharmaceuticals (United States)(Current)

Catholic University of Korea

Pfizer (United States)

The Royal Melbourne Hospital

The Catholic University of Korea Seoul St. Mary's Hospital

Scott T. Rottinghaus is an author at Alexion Pharmaceuticals (United States) specializing in medicine, immunology, and cell biology.

Top concepts

Publications per year

1994–2020

24

Publications

24

Combination Antifungal Therapy for Invasive Aspergillosis

Kieren A. Marr, Haran T. Schlamm, Raoul Herbrecht et al. · Annals of Internal Medicine · 2015 · 486 citations

Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study

Jong Wook Lee, Flore Sicre de Fontbrune, Lily Wong Lee Lee et al. · Blood · 2018 · 379 citations · Full text

Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study

Austin Kulasekararaj, Anita Hill, Scott T. Rottinghaus et al. · Blood · 2018 · 361 citations · Full text

Atm deficiency results in severe meiotic disruption as early as leptonema of prophase I

Carrolee Barlow, Marek Liyanage, Madalena Tarsounas et al. · Development · 1998 · 265 citations

, , +25

The C Terminus of Ku80 Activates the DNA-Dependent Protein Kinase Catalytic Subunit

Belinda K. Singleton, Maria I. Torres‐Arzayus, Scott T. Rottinghaus et al. · Molecular and Cellular Biology · 1999 · 182 citations · Full text

Rows per page

1–5 of 24